The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Highlights from this issue include research showing that traumatic brain injury in US veterans is linked to subsequent brain cancer diagnosis
The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Highlights from this issue include research showing that traumatic brain injury in US veterans is linked to subsequent brain cancer diagnosis
The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Highlights from this issue include research showing that glioblastoma cells mimic neuron cells to evade treatment.
The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Highlights from this issue include research showing that earlier resection of low grade glioma results in improved survival
The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Highlights from this issue include research showing clear clinical benefit of combining dabrafenib and trametinib in BRAF mutated low- and high-grade paediatric gliomas.
The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Highlights from this issue include the announcement of the 2023 International Brain Tumour Awareness Week and positive clinical trial results for oncolytic virus therapy in recurrent glioblastoma
The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Highlights from this issue include the finding that oral drug called vorasidenib lengthens the time until tumour progression in patients with grade glioma compared to placebo.